Atsunari Kawashima
Papers
4
Total Citations
25
H-Index
2
About
Atsunari Kawashima is a urologic surgeon and researcher whose work centers on advancing minimally invasive treatments for urologic cancers, particularly renal cell carcinoma (RCC) and bladder cancer. His major contributions lie in comparing the efficacy and outcomes of nephron-sparing techniques, such as robot-assisted partial nephrectomy (RAPN) versus percutaneous cryoablation (PCA) for T1 RCC, a study that has garnered 19 citations and provides critical guidance for clinical decision-making. Kawashima has also demonstrated that robotic adrenalectomy achieves shorter operative times than laparoscopic approaches, as shown in his propensity score–matched analysis. His research extends to identifying predictive factors for postoperative recovery, including a study linking preoperative C-reactive protein levels to prolonged hospital stays after radical cystectomy for bladder cancer. Additionally, he has reported rare clinical cases, such as perirenal non-specific lymphadenitis mimicking a solitary renal mass, highlighting diagnostic challenges. With a growing citation impact, Kawashima’s work is shaping evidence-based protocols in urologic oncology, offering surgeons and patients clearer insights into the trade-offs between robotic, laparoscopic, and ablative techniques.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4